Close Menu
Home » Editas Medicine to Provide Broad Institute With up to $125M in CRISPR Funding

Editas Medicine to Provide Broad Institute With up to $125M in CRISPR Funding

Jun 11, 2018
|
staff reporter

NEW YORK (GenomeWeb) — CRISPR-based therapeutics developer Editas Medicine has agreed to provide up to $125 million in research funding to the Broad Institute in exchange for the exclusive right to be the first to negotiate for licenses to genome-editing inventions that arise from the sponsored research.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

Maybe Not to Eat…

Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.

Moving From DC to KC

Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.

Just for Fun?

Slate's Jane Hu compares some at-home genetic tests to astrology.

PLOS Has Skin Cancer Risk Scores and More This Week

In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.

What's Popular?

In Business News

  1. Invitae to Acquire Singular Bio for $55M

  2. USPTO Denies Foundation Medicine Attempt to Invalidate Guardant Health Patent

  3. GlaxoSmithKline, UC's Doudna Establish $67M Genomics, CRISPR Research Lab

  4. Invitae Launches Free Genetic Testing Programs With Spark Therapeutics, X4 Pharmaceuticals

  5. Intermountain, Decode Genetics to Sequence 500K Genomes for Research

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.